Table 3.
Medication Changes and Thiazide Use a
| Baseline | 6 Months b | 12 Months | 18 Months | 24 Months | 30 Months | |
|---|---|---|---|---|---|---|
| Intervention discontinued (n=62) | ||||||
| Medication changes | N/A | |||||
| Increased | 35.5 | 21.0 | 14.5 | 4.8 | 21.0 | |
| Decreased | 4.8 | 16.1 | 17.7 | 4.8 | 9.7 | |
| Other change | 37.1 | 11.3 | 9.7 | 1.6 | 14.5 | |
| No change | 22.6 | 51.6 | 58.1 | 88.7 | 54.8 | |
| Intervention continued (n=61) | ||||||
| Medication change | N/A | |||||
| Increased | 31.1 | 24.6 | 27.9 | 1.6 | 26.2 | |
| Decreased | 8.2 | 18.0 | 13.1 | 4.9 | 14.8 | |
| Other change | 45.9 | 21.3 | 11.5 | 1.6 | 11.5 | |
| No change | 14.8 | 36.1 | 47.5 | 91.8 | 47.5 | |
| Thiazides | ||||||
| Intervention discontinued | 45.2 | 61.3 | 54.8 | 59.7 | 58.1 | 51.6 |
| Intervention continued | 41.0 | 52.5 | 57.4 | 62.3 | 62.3 | 59.0 |
Abbreviation: N/A, not applicable. Medication change represents the change from the time period immediately preceding it. aAll values are expressed as percentages. bAll patients received the pharmacist intervention from baseline to 6 months but the two groups are separated at these time points to demonstrate any imbalances at randomization.